13F-HR/A filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR/A for the quarter ended 2019-12-31, filed 2020-02-25, with 4 holding rows worth $1,372,681,000.
- Accession
- 0001213900-20-004679
- Filer
- CIK 1674712
- Filed
- 2020-02-25
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, amendment of type restatement, 49 entries on the cover page, a total value of $1,372,681,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,372,681,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 000Common | 00461U105 | 101,392,395 | $999,991,000 | thousands by filing date | |
| Ascendis Pharma A/S | 000000ADR | 04351P101 | 2,552,237 | $298,732,000 | thousands by filing date | |
| SPOTIFY TECHNOLOGY SA | 000000SHS | SHS | 9,610,156 | $47,333,000 | thousands by filing date | |
| NATURA &CO HOLDING-ADR | 000000ADS | ADS | 2,805,035 | $26,625,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-20-003586 | superseded | 2020-02-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001213900-20-004679 | this filing | 2020-02-25 | acceptance time not in the bulk data set |